Pharmacological treatment in asthma and COPD

Allergology International

Volumn 58, Issue 3, 2009, Pages 341-346

  Hoshino, Tomoaki ^a   Toda, Reiko ^a   Aizawa, Hisamichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Asthma; Bronchodilators; COPD; Inhaled glucocorticosteroids

Indexed keywords

AMINOPHYLLINE; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; BECLOMETASONE; BUDESONIDE; CEFEPIME; CEFPODOXIME; CEFPROZIL; CEFTAZIDIME; CEFUROXIME; FLUTICASONE; FLUTICASONE PROPIONATE PLUS SALMETEROL; IPRATROPIUM BROMIDE; LEVOFLOXACIN; LORACARBEF; METHYLPREDNISOLONE; MONTELUKAST; OXITROPIUM BROMIDE; OXYGEN; PIPERACILLIN PLUS TAZOBACTAM; PRANLUKAST; PREDNISONE; PROCATEROL; SALBUTAMOL; SALMETEROL; THEOPHYLLINE; TIOTROPIUM BROMIDE; TULOBUTEROL; UNINDEXED DRUG; ZAFIRLUKAST;

AIRWAY OBSTRUCTION; ASTHMA; BRONCHUS HYPERREACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY FAILURE; DISEASE EXACERBATION; DRY POWDER; FORCED EXPIRATORY VOLUME; HAEMOPHILUS INFLUENZAE; HUMAN; MEDICAL ASSESSMENT; METERED DOSE INHALER; MORAXELLA CATARRHALIS; NEBULIZER; PATHOPHYSIOLOGY; PATIENT CARE; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSEUDOMONAS; QUALITY OF LIFE; RESPIRATORY TRACT INFLAMMATION; REVIEW; STREPTOCOCCUS PNEUMONIAE; TREATMENT DURATION;

EID: 70450160077     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.09-RAI-0117     Document Type: Review

References (12)

1. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Preventation. Revised 2008. Available at: http://www.ginasthma. com.
2. Haahtela T, Jarvinen M, Kava T et al. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 1991;325:388-392
3. Emerman CL, Cydulka RK. A randomized comparison of 100-mg vs 500-mg dose of methylprednisolone in the treatment of acute asthma. Chest 1995;107:1559-1563
4. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, NHLBI/WHO Workshop Report. Revised 2006. Available at: http://www.Goldcopd.Com. Accessed November 25, 2006.
5. Tashkin DP, Celli B, Senn S et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008;359:1543-1554
6. Calverley PM, Anderson JA, Celli B et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007;356:775-789 (Pubitemid 46294610)
7. Niewoehner DE, Erbland ML, Deupree RH et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of veterans affairs cooperative study group. N Engl J Med 1999;340:1941-1947
8. Quon BS, Gan WQ, Sin DD. Contemporary management of acute exacerbations of COPD: A systematic review and metaanalysis. Chest 2008;133:756-766
9. Bartlett JG. Diagnostic accuracy of transtracheal aspiration bacteriologic studies. Am Rev Respir Dis 1977;115:777-782
10. Soler N, Torres A, Ewig S et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 1998;157:1498-1505 (Pubitemid 28242083)
11. Bandi V, Apicella MA, Mason E et al. Nontypeable haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. Am J Respir Crit Care Med 2001;164:2114-2119 (Pubitemid 34020254)
12. Stoller JK. Clinical practice. Acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002;346:988-994 (Pubitemid 34983250)